A pooled analysis of 3 large multicenter trials confirms a survival advantage for NPM1 (mut) AML in MRD(neg) remission after intensive induction
一项对3项大型多中心试验的汇总分析证实,在强化诱导治疗后达到微小残留病灶阴性缓解的NPM1突变型急性髓系白血病患者具有生存优势。
期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70198
Döhner, Konstanze; Döhner, Hartmut; Späth, Daniela; Kapp-Schwoerer, Silke; Gilkes, Amanda; Thomas, Ian; Johnson, Sean; Potter, Nicola; Bevan, Yana; Othman, Jad; Russell, Nigel H; Röllig, Christoph; Thiede, Christian; Bornhäuser, Martin; Oellerich, Thomas; Hood, Tressa; Elder, Jenna; Carvajal, Luis A; DiMartino, Jorge; Dillon, Richard